Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRI
NCT05464992 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800
Last updated 2026-02-02
Summary
Standard Magnetic Resonance Imaging (MRI) is based on the excitation of hydrogen nuclei that are presents in water molecules, which abundance in human body allows for obtention of superior contrast. However, assessing the presence of other molecules than water in tissues is also of great clinical interest to probe metabolites related to physiological body function and pathological conditions.
Chemical exchange saturation transfer (CEST) allow to overcome some limitations of proton magnetic resonance spectroscopy (1H-MRS) by exploiting chemical properties of the targeted molecule through a continuous process of re-saturation and exchange, and thus detecting it with increased sensitivity, from two orders of magnitude. Moreover, CEST technique is based on imaging sequences and can therefore benefit from well-known fast acquisition strategies, as well as improved spatial resolution.
Conditions
Interventions
- OTHER
-
Additional CEST sequences during PET/MRI exam
CE-Marked Advanced Technology Software Modules (ATSM) for Magnetic Resonance Imaging from General Electric Healthcare
Sponsors & Collaborators
-
Centre Paul Strauss
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-28
- Primary Completion
- 2036-12-28
- Completion
- 2036-12-28
Countries
- France
Study Locations
More Related Trials
-
Non-invasive MRI Subclassification of Heptocellular Carcinoma - HepCaSt-Study
NCT05202015 ·Status: UNKNOWN
-
Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging
NCT02311556 ·Status: COMPLETED ·Phase: PHASE1
-
Quantitative MRI in Assessing Disease in Patients With Brain Tumors
NCT02269111 ·Status: TERMINATED ·Phase: NA
-
Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions
NCT02156739 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
GlucoCEST MRI in Oncology
NCT03212157 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic Cancers
NCT02966574 ·Status: UNKNOWN ·Phase: NA
-
18F-Fluoro-Ethyl-Tyrosine (FET) Positron Emission Tomography (PET) and Grading Glioma
NCT04001257 ·Status: COMPLETED
-
PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy
NCT04272658 ·Status: RECRUITING
-
Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom
NCT05140902 ·Status: COMPLETED ·Phase: NA
-
Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme
NCT01873469 ·Status: COMPLETED
-
Applying PET/MR in Neuroendocrine Tumors - Imaging Dynamic Processes in Both Modalities
NCT04152928 ·Status: UNKNOWN ·Phase: NA
-
Study of the Angiogenesis by PET/CT in Patients With Lymphoma
NCT02490891 ·Status: COMPLETED ·Phase: PHASE2
-
Deuterium Metabolic MRI and [18F]FDG PET for Assessment of Treatment Response Following Radioembolization
NCT06232889 ·Status: RECRUITING ·Phase: NA
-
Early Therapy Response Monitoring in Melanoma Patients Using PET/MRI
NCT03132090 ·Status: UNKNOWN ·Phase: NA
-
Positron Emission Tomography/Magnetic Resonance Imaging in Patients
NCT01557881 ·Status: TERMINATED ·Phase: NA
-
Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer
NCT03442504 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PET/MRI Perfusion and CT Perfusion in Solid Tumors
NCT02314962 ·Status: TERMINATED
-
Dynamic F-DOPA PET for Differential Diagnosis Between Recurrence and Radionecrosis of Brain Metastasis
NCT05762172 ·Status: COMPLETED ·Phase: NA
-
Comparison Study Between PET/CT and Whole-Body Diffusion Weighted MRI in the Detection of Distant Malignancies
NCT06205901 ·Status: NOT_YET_RECRUITING
-
Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging for Hepatic Malignancies
NCT04332419 ·Status: COMPLETED ·Phase: NA
-
MRI Perfusion on T1 and T2 Brain Lesion(s)
NCT02250755 ·Status: COMPLETED ·Phase: NA
-
Gadoxetate Abbreviated MRI in Metastatic Colorectal Cancer
NCT05314400 ·Status: RECRUITING ·Phase: NA
-
Assessment of the Impact of Acquisition Time, Respiratory Gating and New Qclear Reconstruction Modalities on the Quantification of Dosimetry in Selective Internal Radiotherapy
NCT04903340 ·Status: COMPLETED
-
FET-PET Directed Simultaneous In-field Boost for Primary GBM
NCT04790097 ·Status: COMPLETED ·Phase: NA
-
A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.
NCT01083719 ·Status: UNKNOWN ·Phase: PHASE2